Vistin Pharma ASA (LTS:0RAM)
kr 27.6 0 (0%) Market Cap: 1.18 Bil Enterprise Value: 1.18 Bil PE Ratio: 19.84 PB Ratio: 3.90 GF Score: 72/100

Q4 2021 Vistin Pharma ASA Earnings Call Transcript

Feb 17, 2022 / 07:30AM GMT
Release Date Price: kr20.8
Operator

Good day, and thank you for standing by. Welcome to Vistin Pharma Fourth Quarter 2021 Quarterly Report Conference Call. (Operator Instructions) After the speaker's presentation, there will be a question-and-answer session. (Operator Instructions) Please be advised that today's conference is being recorded. (Operator Instructions)

And now I'd like to hand the conference over to your speaker host today, Mr. Alexander Karlsen, CFO of Vistin Pharma. Thank you. Please go ahead, sir.

Alexander Karlsen
Vistin Pharma ASA - CFO

Hello, everyone, and good morning. Welcome to the fourth quarter presentation. And today's presentation will be held by myself, Alexander Karlsen, the CFO. And I also have with me Magnus Tolleshaug, which is the CCO and the Interim CEO.

I'm now handing the word over to you, Magnus.

Magnus Tolleshaug
Vistin Pharma ASA - Commercial Director

Thank you for that, Alexander. I will go through the highlights of the fourth quarter and the preliminary 2021 results.

So the Q4 2021

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot